MSFHR partners on $31.5M national dementia research initiative
10 September 2014
The Michael Smith Foundation for Health Research is proud to partner on a new national initiative that will tackle the growing prevalence of dementia and related illnesses, including Alzheimer’s disease.
The Canadian Consortium on Neurodegeneration in Aging (CCNA), announced today by federal health minister Rona Ambrose, brings together 20 research teams and experts from across Canada to focus on preventing and delaying the onset of dementia as well as improving the quality of life for Canadians affected by these illnesses.
The initiative is supported by a national partnership between the Canadian Institutes of Health Research and 13 organizations from the public and private sectors, including MSFHR. Total funding of $31.5 million over five years has been committed by the Government of Canada and the partner organizations.
“The Michael Smith Foundation for Health Research is proud to support the efforts of BC researchers who are leading nationwide teams focused on unraveling the mysteries of Alzheimer’s disease and related dementias,” said MSFHR president and CEO Dr. Diane Finegood. “Collaboration between excellent researchers, patients, and care providers will help us find solutions to this devastating health issue affecting tens of thousands of Canadians and their families.”
CCNA will help address a major public health issue confronting Canada’s aging population. The number of Canadians living with dementia is expected to double by 2031 to an estimated 1.4 million. The cost to the Canadian economy of such an increase is estimated at nearly $300 billion per year.
The CCNA partnership builds on MSFHR’s ongoing work to address neurodegeneration and dementia. The BC Alzheimer’s Research Award, launched in December 2013 in partnership with Brain Canada, Genome BC, and the Pacific Alzheimer Research Foundation, commits $7.5 million to support BC research teams investigating new approaches to prevention, diagnosis, and treatment of Alzheimer’s disease. Results of this funding competition will be announced in fall 2014.